Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party-Reference-Cited by-同舟云学术

Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

Published:2023-02-22 Issue:5 Volume:58 Page:603-606
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Greco Raffaella^ORCID,Hoogenboom Jorinde D.,Bonneville Edouard F.^ORCID,Anagnostopoulos Achilles^ORCID,Cuoghi Angela,Dalle Jean-Hugues,Weissinger Eva M.,Lang Peter^ORCID,Galaverna Federica,Martino Massimo^ORCID,Maschan Alexei^ORCID,Mauz-Körholz Christine^ORCID,Noviello Maddalena,Passweg Jakob,Peccatori Jacopo,Rovira Montserrat,Solano Carlos,Veelken Hendrik^ORCID,Velardi Andrea,Wagner-Drouet Eva Maria,Zhang Xi^ORCID,Ciceri Fabio^ORCID,Bonini Chiara^ORCID,Vago Luca^ORCID,Ruggeri Annalisa^ORCID,Chabannon Christian^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-01939-z.pdf

Reference17 articles.

1. Williams L, Cirrone F, Cole K, Abdul-Hay M, Luznik L, Al-Homsi AS. Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation. Front Immunol. 2020;11:636 https://doi.org/10.3389/fimmu.2020.00636.

2. Oltolini C, Greco R, Galli L, Clerici D, Lorentino F, Xue E, et al. Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching. Biol Blood Marrow Transpl. 2020;26:1179–88. https://doi.org/10.1016/j.bbmt.2020.01.013.

3. Cieri N, Oliveira G, Greco R, Forcato M, Taccioli C, Cianciotti B, et al. Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation. Blood. 2015;125:2865–74. https://doi.org/10.1182/blood-2014-11-608539.

4. Goldsmith SR, Abid MB, Auletta JJ, Bashey A, Beitinjaneh A, Castillo P, et al. Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis. Blood. 2021;137:3291–305.

5. Lin A, Flynn J, DeRespiris L, Figgins B, Griffin M, Lau C, et al. Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis. Transpl Cell Ther. 2021;27:85.e1–85.e6. https://doi.org/10.1016/j.bbmt.2020.10.009.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: 50 years of BMT: conditioning regimens and early complications after transplantation;Frontiers in Oncology;2024-02-07

2. Clinical and Biological Concepts for Mastering Immune Reconstitution After Hematopoietic Cell Transplantation: Toward Practical Guidelines and Greater Harmonization;The EBMT Handbook;2024

3. Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management. A report from the CMV International Symposium 2023;Transplant Infectious Disease;2023-11-09

4. Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir;Bone Marrow Transplantation;2023-07-19